These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11586277)

  • 21. Intravenous Immunoglobulin in the Treatment of Primary Immunodeficiency Diseases.
    De Ranieri D; Fenny NS
    Pediatr Ann; 2017 Jan; 46(1):e8-e12. PubMed ID: 28079912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-mediated remyelination: relevance to multiple sclerosis.
    Bieber A; Asakura K; Warrington A; Kaveri SV; Rodriguez M
    Mult Scler; 2000 Oct; 6 Suppl 2():S1-5; discussion S33. PubMed ID: 11188771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approaches in the therapy of immunodeficiency.
    Fleisher TA; Blaese RM
    Allergy Proc; 1993; 14(6):409-11. PubMed ID: 8157164
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous and subcutaneous immunoglobulin G replacement therapy.
    Bonilla FA
    Allergy Asthma Proc; 2016 Nov; 37(6):426-431. PubMed ID: 27931296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indications of plasma exchanges in combination with intravenous immunoglobulins or therapeutic monoclonal antibodies. How to combine them?
    Vendramin C; Scully M
    Presse Med; 2019 Nov; 48(11 Pt 2):354-359. PubMed ID: 31679899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin: a review.
    Eibl MM; Wedgwood RJ
    Immunodefic Rev; 1989; 1 Suppl():1-42. PubMed ID: 2698646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Established and new uses of intravenous immunoglobulin.
    Cunningham-Rundles C
    Mt Sinai J Med; 1992 Sep; 59(4):335-40. PubMed ID: 1406751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody production: polyclonal-derived biotherapeutics.
    Newcombe C; Newcombe AR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):2-7. PubMed ID: 16893686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic and topical immunoglobulin treatment in immunocompromised patients.
    Hammarström L; Gardulf A; Hammarström V; Janson A; Lindberg K; Smith CI
    Immunol Rev; 1994 Jun; 139():43-70. PubMed ID: 7523279
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous therapy with gamma globulin.
    Dwyer JM
    Adv Intern Med; 1987; 32():111-35. PubMed ID: 3548246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG.
    Chua I; Lagos M; Charalambous BM; Workman S; Chee R; Grimbacher B
    J Allergy Clin Immunol; 2011 Jun; 127(6):1410-1. PubMed ID: 21376379
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent advances in the pathophysiology of primary immune deficiencies and immunoglobulin therapy in HIV infection and autoimmune/inflammatory neurological disorders. Symposium proceedings. Indian Wells, California, January 24-25, 1992.
    Pediatr Res; 1993 Jan; 33(1 Suppl):S1-100. PubMed ID: 8094549
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous immune globulins. A review of their uses in selected immunodeficiency and autoimmune diseases.
    Pirofsky B; Kinzey DM
    Drugs; 1992 Jan; 43(1):6-14. PubMed ID: 1372861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
    Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous Immunoglobulin: Mechanism of Action in Autoimmune and Inflammatory Conditions.
    Bayry J; Ahmed EA; Toscano-Rivero D; Vonniessen N; Genest G; Cohen CG; Dembele M; Kaveri SV; Mazer BD
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1688-1697. PubMed ID: 37062358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgG replacement therapy, no size fits all.
    Bonilla FA
    Clin Immunol; 2011 May; 139(2):107-9. PubMed ID: 21420364
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical use of intravenous immunoglobulin IgG].
    Permin H; Herlin T; Koch HG; Pedersen FK
    Ugeskr Laeger; 1992 Nov; 154(48):3411-6. PubMed ID: 1334293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signaling by Antibodies: Recent Progress.
    Bournazos S; Wang TT; Dahan R; Maamary J; Ravetch JV
    Annu Rev Immunol; 2017 Apr; 35():285-311. PubMed ID: 28446061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.